Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system

被引:24
|
作者
Takei, Hiroaki [1 ,2 ,4 ]
Shinoda, Jun [1 ,2 ,3 ]
Ikuta, Soko [5 ]
Maruyama, Takashi [5 ]
Muragaki, Yoshihiro [5 ]
Kawasaki, Tomohiro [1 ,2 ,4 ]
Ikegame, Yuka [1 ,2 ,3 ]
Okada, Makoto [1 ,2 ]
Ito, Takeshi [1 ,2 ]
Asano, Yoshitaka [1 ,2 ,3 ]
Yokoyama, Kazutoshi [1 ,2 ]
Nakayama, Noriyuki [4 ]
Yano, Hirohito [4 ]
Iwama, Toru [4 ]
机构
[1] Kizawa Mem Hosp, Dept Neurosurg, Minokamo, Gifu, Japan
[2] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Gifu, Japan
[3] Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, Gifu, Japan
[4] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan
[5] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan
基金
日本学术振兴会;
关键词
C-11-methionine; C-11-choline; F-18-fluorodeoxyglucose; positron emission tomography; glioma; isocitrate dehydrogenase mutation; oncology; C-11-METHIONINE PET; C-11; METHIONINE; IDH2; MUTATIONS; BRAIN-TUMORS; F-18-FDG PET; SURVIVAL; C-11-CHOLINE; DIAGNOSIS; NECROSIS; CHOLINE;
D O I
10.3171/2019.5.JNS19780
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Positron emission tomography (PET) is important in the noninvasive diagnostic imaging of gliomas. There are many PET studies on glioma diagnosis based on the 2007 WHO classification; however, there are no studies on glioma diagnosis using the new classification (the 2016 WHO classification). Here, the authors investigated the relationship between uptake of 11C-methionine (MET), 11C-choline (CHO), and 18F-fluorodeoxyglucose (FDG) on PET imaging and isocitrate dehydrogenase (IDH) status (wild-type [IDH-wt] or mutant [IDH-mut]) in astrocytic and oligodendroglial tumors according to the 2016 WHO classification. METHODS: In total, 105 patients with newly diagnosed cerebral gliomas (6 diffuse astrocytomas [DAs] with IDH-wt, 6 DAs with IDH-mut, 7 anaplastic astrocytomas [AAs] with IDH-wt, 24 AAs with IDH-mut, 26 glioblastomas [GBMs] with IDH-wt, 5 GBMs with IDH-mut, 19 oligodendrogliomas [ODs], and 12 anaplastic oligodendrogliomas [AOs]) were included. All OD and AO patients had both IDH-mut and 1p/19q codeletion. The maximum standardized uptake value (SUV) of the tumor/mean SUV of normal cortex (T/N) ratios for MET, CHO, and FDG were calculated, and the mean T/N ratios of DA, AA, and GBM with IDH-wt and IDH-mut were compared. The diagnostic accuracy for distinguishing gliomas with IDH-wt from those with IDH-mut was assessed using receiver operating characteristic (ROC) curve analysis of the mean T/N ratios for the 3 PET tracers. RESULTS: There were significant differences in the mean T/N ratios for all 3 PET tracers between the IDH-wt and IDH-mut groups of all histological classifications (p < 0.001). Among the 27 gliomas with mean T/N ratios higher than the cutoff values for all 3 PET tracers, 23 (85.2%) were classified into the IDH-wt group using ROC analysis. In DA, there were no significant differences in the T/N ratios for MET, CHO, and FDG between the IDH-wt and IDH-mut groups. In AA, the mean T/N ratios of all 3 PET tracers in the IDH-wt group were significantly higher than those in the IDH-mut group (p < 0.01). In GBM, the mean T/N ratio in the IDH-wt group was significantly higher than that in the IDH-mut group for both MET (p = 0.034) and CHO (p = 0.01). However, there was no significant difference in the ratio for FDG. CONCLUSIONS: PET imaging using MET, CHO, and FDG was suggested to be informative for preoperatively differentiating gliomas according to the 2016 WHO classification, particularly for differentiating IDH-wt and IDH-mut tumors.
引用
收藏
页码:1010 / 1019
页数:10
相关论文
共 50 条
  • [1] Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteria
    Miyake, Keisuke
    Suzuki, Kenta
    Ogawa, Tomoya
    Ogawa, Daisuke
    Hatakeyama, Tetsuhiro
    Shinomiya, Aya
    Kudomi, Nobuyuki
    Yamamoto, Yuka
    Nishiyama, Yoshihiro
    Tamiya, Takashi
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [2] World Health Organization 2016 Classification of Central Nervous System Tumors
    Diamandis, Phedias
    Aldape, Kenneth
    NEUROLOGIC CLINICS, 2018, 36 (03) : 439 - +
  • [3] The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
    David N. Louis
    Arie Perry
    Guido Reifenberger
    Andreas von Deimling
    Dominique Figarella-Branger
    Webster K. Cavenee
    Hiroko Ohgaki
    Otmar D. Wiestler
    Paul Kleihues
    David W. Ellison
    Acta Neuropathologica, 2016, 131 : 803 - 820
  • [4] The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
    Louis, David N.
    Perry, Arie
    Reifenberger, Guido
    von Deimling, Andreas
    Figarella-Branger, Dominique
    Cavenee, Webster K.
    Ohgaki, Hiroko
    Wiestler, Otmar D.
    Kleihues, Paul
    Ellison, David W.
    ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 803 - 820
  • [5] Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016
    Malzkorn, Bastian
    Reifenberger, Guido
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (06) : 494 - 501
  • [6] Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification
    Ochirjav, Enkhee
    Enkhbat, Bayarmaa
    Baldandorj, Tuul
    Choe, Gheeyoung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2019, 53 (05) : 298 - 307
  • [7] Molecular subgrouping of gliomatosis cerebri according to the 2016 World Health Organization classification of tumors of the central nervous system
    Kwon, Mi Jung
    Suh, Yeon-Lim
    Cho, Haeyon
    Kang, So Young
    BRAIN PATHOLOGY, 2019, 29 : 43 - 44
  • [8] Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification
    Ly, K. Ina
    Wen, Patrick Y.
    Huang, Raymond Y.
    NEUROLOGIC CLINICS, 2020, 38 (01) : 95 - +
  • [9] World health organization classification of central nervous system tumors
    Rees, JH
    Smirniotopoulos, JG
    Jones, RV
    RADIOLOGY, 1996, 201 : 77 - 77
  • [10] 2016 World Health Organization Classification of Central Nervous System Tumors: An Era of Molecular Biology
    Hoshide, Reid
    Jandial, Rahul
    WORLD NEUROSURGERY, 2016, 94 : 561 - 562